Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-2,000
Closed -$89K – 6805
2020
Q4
$89K Sell
2,000
-3,600
-64% -$124K ﹤0.01% 5624
2020
Q3
$162K Sell
5,600
-1,700
-23% -$53.4K ﹤0.01% 4764
2020
Q2
$259K Sell
7,300
-13,500
-65% -$569K ﹤0.01% 4822
2020
Q1
$1.08M Sell
20,800
-5,500
-21% -$264K ﹤0.01% 3095
2019
Q4
$1.8M Sell
26,300
-64,100
-71% -$4.02M ﹤0.01% 3111
2019
Q3
$4.33M Buy
90,400
+18,200
+25% +$949K ﹤0.01% 2070
2019
Q2
$4.82M Buy
72,200
+44,800
+164% +$3.41M ﹤0.01% 2011
2019
Q1
$2.61M Buy
27,400
+2,900
+12% +$362K ﹤0.01% 2390
2018
Q4
$3.04M Buy
24,500
+15,600
+175% +$2.57M ﹤0.01% 2287
2018
Q3
$2.17M Buy
+8,900
New +$2.06M ﹤0.01% 2654

Other funds holding INGN

Citigroup's INGN Position: Q3 2026 in Review

Citigroup reduced its Inogen (INGN) stake by 89% in Q3 2026, selling an estimated $60K and leaving 1,211 shares worth $6.38K. The position accounts for ﹤0.01% of the portfolio, ranked #5308.

Citigroup first reported a position in INGN in Q1 2014 and has held it in 51 quarters since. The position peaked at $4.66M in Q2 2019. 50 funds tracked by Wall St. Rank hold INGN as of Q3 2026.

  • Citigroup held 1,211 shares of Inogen worth $6.38K as of Q3 2026.
  • Citigroup sold 10,211 Inogen shares in Q3 2026, an estimated $60K.
  • Inogen made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5308 holding.
  • Citigroup first reported a position in Inogen in Q1 2014 and has held it in 51 quarters since.
  • Citigroup's Inogen position peaked at $4.66M in Q2 2019.
  • 50 funds tracked by Wall St. Rank held Inogen as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.